Replimune Group, Inc. (REPL)

Replimune Group Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	826	751	502	1,001	802	1,419
Market Cap Growth	12.10%	49.72%	-49.87%	24.82%	-43.49%	288.25%
Enterprise Value	579	290	111	445	414	959
Last Close Price	10.53	9.75	8.17	17.66	16.98	30.51
PB Ratio	3.14	1.81	1.34	1.80	1.95	2.84
P/TBV Ratio	3.14	1.81	1.34	1.80	1.95	2.84
Debt / Equity Ratio	0.29	0.18	0.20	0.11	0.08	0.07
Quick Ratio	6.15	7.82	10.53	17.33	19.31	33.03
Current Ratio	6.31	7.95	10.72	17.52	19.46	33.25
Return on Equity (ROE)	-96.24%	-62.58%	-46.42%	-36.06%	-25.94%	-23.70%
Return on Assets (ROA)	-44.83%	-31.26%	-25.66%	-19.65%	-14.33%	-12.41%
Return on Capital (ROIC)	-49.91%	-34.47%	-27.29%	-20.54%	-14.75%	-12.73%
Return on Capital Employed (ROCE)	-94.60%	-53.10%	-52.10%	-28.40%	-26.10%	-14.60%
Earnings Yield	-37.56%	-32.93%	-43.03%	-17.42%	-14.73%	-5.70%
FCF Yield	-32.65%	-26.49%	-38.11%	-13.03%	-10.54%	-4.50%
Buyback Yield / Dilution	-27.30%	-21.02%	-14.36%	-11.49%	-12.89%	-34.99%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q